Matthew Gubin, PhD, postdoctoral research scholar in the laboratory of Robert Schreiber, PhD, Alumni Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has received a three-year, $164,500 grant from the Cancer Research Institute for research titled “Using Genomics to Identify Targets of Checkpoint Blockade Cancer Treatment and Identify Optimal Target Antigens for Vaccination.”
Latest from the Record
Announcements
MetroLink stations undergo construction
Notables
Pinski essay recognized by Lasker Foundation
Brown School faculty join national effort to advance psychedelic therapy education
Obituaries
Sandra Geary, pianist in Arts & Sciences, 59